help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bertheau, P.
Right arrow Articles by Merino, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertheau, P.
Right arrow Articles by Merino, M. J.

American Journal of Pathology, Vol 145, 26-32, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

NM23 protein in neoplastic and nonneoplastic thyroid tissues

P Bertheau, A De La Rosa, PS Steeg and MJ Merino
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892.

The expression of nm23 gene products has been associated with a lower metastatic potential and better outcome in malignant tumors. We have used immunohistochemistry to study the expression of nm23 protein in thyroid tissues from 101 patients consisting of 78 malignant neoplasms, 13 adenomas, and 10 other benign conditions. Cytoplasmic staining for nm23 protein was identified in normal tissues and in most benign and malignant lesions and did not correlate with either histological type of clinical outcome. Nuclear staining was seen in 93% of normal tissues and in 29% of primary carcinomas of the thyroid and was associated with a longer disease-free survival (P = 0.03). Membranous staining was present in some tumors but absent in normal thyroid. In conclusion, nm23 protein has a combined pattern of distribution among subcellular compartments in thyroid tissues. Although there was no significant association between cytoplasmic or membranous expression and histological type of tumor or survival nm23 nuclear expression may be a useful marker in assessing the evolution of thyroid tumors.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
C. Zafon, G. Obiols, J. CastellvI, N. Tallada, P. Galofre, E. Gemar, J. Mesa, and R. Simo
nm23-H1 Immunoreactivity as a Prognostic Factor in Differentiated Thyroid Carcinoma
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3975 - 3980.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.